Wright Investors Service’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.83M Sell
13,010
-3,995
-23% -$886K 0.89% 31
2025
Q4
$3.89M Buy
17,005
+1,757
+12% +$400K 1.17% 25
2025
Q3
$3.53M Sell
15,248
-4,517
-23% -$920K 1.02% 26
2025
Q2
$3.67M Sell
19,765
-18,541
-48% -$3.45M 1.11% 26
2025
Q1
$8.03M Buy
38,306
+3,826
+11% +$744K 2.65% 7
2024
Q4
$6.13M Sell
34,480
-14,046
-29% -$2.58M 1.99% 13
2024
Q3
$9.58M Buy
48,526
+3,880
+9% +$724K 2.51% 7
2024
Q2
$7.66M Sell
44,646
-5,793
-11% -$960K 2.02% 13
2024
Q1
$9.18M Buy
50,439
+4,167
+9% +$718K 2.33% 8
2023
Q4
$7.17M Buy
46,272
+6,438
+16% +$939K 2.02% 9
2023
Q3
$5.94M Buy
39,834
+577
+1% +$84.7K 1.72% 14
2023
Q2
$5.29M Sell
39,257
-2,581
-6% -$378K 1.49% 15
2023
Q1
$6.67M Sell
41,838
-54
-0.1% -$8.26K 1.9% 7
2022
Q4
$6.77M Sell
41,892
-10,996
-21% -$1.69M 1.94% 8
2022
Q3
$7.1M Sell
52,888
-1,226
-2% -$176K 2.23% 5
2022
Q2
$8.29M Buy
54,114
+11,989
+28% +$1.83M 2.37% 5
2022
Q1
$6.83M Buy
42,125
+527
+1% +$76.6K 1.7% 12
2021
Q4
$5.63M Buy
41,598
+2,484
+6% +$293K 1.42% 18
2021
Q3
$4.22M Sell
39,114
-3,503
-8% -$400K 1.2% 22
2021
Q2
$4.8M Buy
42,617
+7,621
+22% +$858K 1.3% 19
2021
Q1
$3.79M Sell
34,996
-6,011
-15% -$643K 1.15% 24
2020
Q4
$4.39M Sell
41,007
-7,390
-15% -$710K 1.51% 13
2020
Q3
$4.24M Sell
48,397
-2,367
-5% -$223K 1.51% 13
2020
Q2
$4.98M Sell
50,764
-5,581
-10% -$491K 1.91% 13
2020
Q1
$4.29M Sell
56,345
-4,002
-7% -$341K 1.85% 14
2019
Q4
$5.34M Sell
60,347
-1,780
-3% -$148K 1.83% 12
2019
Q3
$4.7M Buy
62,127
+33,689
+118% +$2.31M 1.69% 14
2019
Q2
$2.07M Sell
28,438
-5,297
-16% -$416K 0.79% 40
2019
Q1
$2.72M Sell
33,735
-3,724
-10% -$305K 1.1% 28
2018
Q4
$3.45M Sell
37,459
-7,457
-17% -$656K 1.48% 20
2018
Q3
$4.25M Sell
44,916
-95
-0.2% -$9.01K 1.55% 17
2018
Q2
$4.17M Sell
45,011
-4,221
-9% -$412K 1.66% 16
2018
Q1
$4.66M Sell
49,232
-5,421
-10% -$596K 1.6% 15
2017
Q4
$5.29M Buy
54,653
+3,908
+8% +$368K 1.77% 12
2017
Q3
$4.51M Sell
50,745
-810
-2% -$61.7K 1.64% 12
2017
Q2
$3.74M Buy
51,555
+9,610
+23% +$646K 1.41% 15
2017
Q1
$2.73M Buy
41,945
+2,360
+6% +$148K 1.11% 21
2016
Q4
$2.48M Sell
39,585
-7,835
-17% -$478K 1.07% 19
2016
Q3
$2.99M Buy
47,420
+28,380
+149% +$1.84M 1.25% 15
2016
Q2
$1.18M Buy
+19,040
New +$1.16M 0.49% 69
2015
Q4
Sell
-7,280
Closed -$396K 241
2015
Q3
$396K Buy
+7,280
New +$474K 0.18% 162
2015
Q1
Sell
-4,569
Closed -$299K 206
2014
Q4
$299K Sell
4,569
-2,542
-36% -$160K 0.15% 179
2014
Q3
$411K Sell
7,111
-363
-5% -$20.2K 0.2% 144
2014
Q2
$422K Buy
+7,474
New +$392K 0.19% 156

Other funds holding ABBV

Wright Investors Service's ABBV Position: Q1 2026 in Review

Wright Investors Service reduced its AbbVie (ABBV) stake by 23% in Q1 2026, selling an estimated $886K and leaving 13,010 shares worth $2.83M. The position accounts for 0.89% of the portfolio, ranked #31.

Wright Investors Service first reported a position in ABBV in Q2 2014 and has held it in 44 quarters since. The position peaked at $9.58M in Q3 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Wright Investors Service held 13,010 shares of AbbVie worth $2.83M as of Q1 2026.
  • Wright Investors Service sold 3,995 AbbVie shares in Q1 2026, an estimated $886K.
  • AbbVie made up 0.89% of Wright Investors Service's portfolio in Q1 2026, its #31 holding.
  • Wright Investors Service first reported a position in AbbVie in Q2 2014 and has held it in 44 quarters since.
  • Wright Investors Service's AbbVie position peaked at $9.58M in Q3 2024.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Wright Investors Service's 13F filing for Q1 2026, filed 29 Apr 2026.